Welcome to Drug and Alcohol Treatment
| ||
Drug Treatment Uremia Article
This is a selection made from among articles on Drug Treatment Uremia. For a permanent link to this article, or to bookmark it for future reading, click here.
Alcohol Treatment Therapy in California
from:by David Richards
California is often thought of as the leader in innovation solutions to both modern and historically problems. When it comes to treatment for alcoholism this tradition continues. They are in the forefront of developing cutting edge alcohol treatment therapy programs that are being adopted around the world to help curb addiction.Alcoholism known no age or class boundaries; everyone from children to senior citizens from all walks of life can be affected. Through innovative substance abuse programs such as specialized camps, licensed therapists and peer support groups many people are finding getting treatment for their addiction is easier and more supporting than ever before. Many people do not seek treatment for alcohol abuse because of concerns over the perception associated with attending many of the traditional abuse programs offered around the country. With these new addiction treatment programs it is now being looked up by many as the "right thing to do" and a "sign of strength" to be enrolled in such a support group.One of the more innovative programs introduced within the last few years is camps and treatment ranches where those seeking treatment go to be around licensed professionals who can help people identify their addiction and find ways to solve it. The programs combine traditional alcohol abuse treatment with relaxation and group-building exercises such as horseback riding, hiking and in some cases relieving the stress associated with breaking the addiction by taking that stress and turn it into good by building houses for low-income households.Alcoholism affects everyone in some way or another - either directly or indirectly by being a family member, co-worker or spouse of the person with the addiction. With new programs and positive reinforcement more people are beginning to seek treatment to help build a better future.
David Richards is a writer and internet publisher who likes to write about alcoholism treatment and self help issues in general. Check out his news and in depth information website 1st-alcoholism-treatment.com
Drug Treatment Uremia Specific links
Drug Treatment Uremia News
Understanding, Treating Chronic Kidney Disease - VetPracticeNews.com
 VetPracticeNews.com | Understanding, Treating Chronic Kidney Disease VetPracticeNews.com But thanks to both traditional and cutting-edge methods for diagnosing and treating the condition, veterinarians have more options than ever for helping these animals enjoy longer lives. In most cases of chronic kidney disease, the underlying cause is ... |
Questcor Pharmaceuticals to Present at Jefferies 2012 Global Healthcare Conference - MarketWatch (press release)
Questcor Pharmaceuticals to Present at Jefferies 2012 Global Healthcare Conference MarketWatch (press release) Questcor's primary product is HP Acthar® Gel (repository corticotropin injection), an injectable drug that is approved by the FDA for the treatment of 19 indications. Of these 19 indications, Questcor currently generates substantially all of its net ... |
This Biotech Needs to Strike Fast - DailyFinance
This Biotech Needs to Strike Fast DailyFinance Alexion Pharmaceuticals' (NAS: ALXN) Soliris, for instance, is the only drug approved to reduce hemolysis in paroxysmal nocturnal hemoglobinuria patients and treat another ultra-rare disease called atypical hemolytic uremic syndrome. |
Thallion and LFB Report Positive Top-Line Results from the Phase II SHIGATEC ... - MarketWatch (press release)
Thallion and LFB Report Positive Top-Line Results from the Phase II SHIGATEC ... MarketWatch (press release) There are presently no drugs approved for treating STEC infections or their associated medical complications. Shigamabs(R) uses a proven anti-toxin approach to neutralize the two types of toxins secreted by pathogenic E. coli with the intent of ... |
Questcor Pharmaceuticals Expands Repurchase Program - MarketWatch (press release)
Questcor Pharmaceuticals Expands Repurchase Program MarketWatch (press release) Questcor's primary product is HP Acthar® Gel (repository corticotropin injection), an injectable drug that is approved by the FDA for the treatment of 19 indications. Of these 19 indications, Questcor currently generates substantially all of its net ... |
“Success” in the world of orphan drug development: it's a matter of perspective - MedCity News
“Success” in the world of orphan drug development: it's a matter of perspective MedCity News To date, the US Food & Drug Administration (FDA) has approved “orphan drugs” to treat rather more than 250 of these disorders (with greater or lesser degrees of efficacy and safety). Considering the situation in 1983, at the time of original passage of ... |
Questcor Pharmaceuticals to Present at Bank of America Merrill Lynch 2012 ... - MarketWatch (press release)
Questcor Pharmaceuticals to Present at Bank of America Merrill Lynch 2012 ... MarketWatch (press release) Questcor's primary product is HP Acthar® Gel (repository corticotropin injection), an injectable drug that is approved by the FDA for the treatment of 19 indications. Of these 19 indications, Questcor currently generates substantially all of its net ... |
Questcor Pharmaceuticals Expands Repurchase Program - PR Newswire (press release)
Questcor Pharmaceuticals Expands Repurchase Program PR Newswire (press release) Questcor's primary product is HP Acthar® Gel (repository corticotropin injection), an injectable drug that is approved by the FDA for the treatment of 19 indications. Of these 19 indications, Questcor currently generates substantially all of its net ... |
What is restless leg syndrome and how is it treated? - Newsolio
 Newsolio | What is restless leg syndrome and how is it treated? Newsolio RLS can be diagnosed and treated. Restless Leg Syndrome (RLS), a neurological movement disorder, can range from mild to extreme. Those who suffer from the symptoms of the disorder claim that it is merely a “creepy crawly” sensation in their legs that ... |
Alexion Pharmaceuticals Management Presents at Deutsche Bank Securities, Inc ... - Seeking Alpha
Alexion Pharmaceuticals Management Presents at Deutsche Bank Securities, Inc ... Seeking Alpha It's in Phase 2. We acquired this drug recently from Enobia. cPMP replacement therapy for molybdenum cofactor deficiency Type A, this is in preclinical phase. This was acquired last year from Orphatec. TT30 comes into Alexion from Taligen. |